Trial Profile
A trial to assess first-line therapy with gimeracil/oteracil/tegafur + cisplatin in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Aug 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 09 Aug 2015 New trial record